Related references
Note: Only part of the references are listed.The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women
Diede L. Loopik et al.
GYNECOLOGIC ONCOLOGY (2020)
Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study
Olaf Reich et al.
GYNECOLOGIC ONCOLOGY (2020)
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
Elizabeth T. H. Fontham et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
Andrea Ciavattini et al.
VACCINES (2020)
Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature
Carlo A. Liverani et al.
JOURNAL OF ONCOLOGY (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014
Nancy M. McClung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women
Karoliina Aro et al.
GYNECOLOGIC ONCOLOGY (2019)
Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System
Maxime Pichon et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Age-Related Changes in the Fraction of Cervical Intraepithelial Neoplasia Grade 3 Related to HPV Genotypes Included in the Nonavalent Vaccine
Luca Giannella et al.
JOURNAL OF ONCOLOGY (2019)
Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women
Chelse Spinner et al.
PEDIATRICS (2019)
What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
Rebecca Landy et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Screening for Cervical Cancer US Preventive Services Task Force Recommendation Statement
Susan J. Curry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study
Talia Malagon et al.
LANCET ONCOLOGY (2018)
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer An Observational Cohort Study
Philip E. Castle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Age-related changes in pre- and post-conization HPV genotype distribution among women with high-grade cervical intraepithelial neoplasia
Luca Giannella et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2017)
Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference
Paolo Giorgi Rossi et al.
PREVENTIVE MEDICINE (2017)
Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
S. Perez et al.
VIROLOGY JOURNAL (2017)
Age-related changes in the diagnostic assessment of women with severe cervical lesions
L. Giannella et al.
CLIMACTERIC (2015)
The incidence of human papillomavirus infection following treatment for cervical neoplasia: A systematic review
Anne F. Rositch et al.
GYNECOLOGIC ONCOLOGY (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
HPV-based screening for prevention of invasive cervical cancer Reply
Guglielmo Ronco et al.
LANCET (2014)
The Distribution of High-Risk Human Papillomaviruses Is Different in Young and Old Patients with Cervical Cancer
Mariano Guardado-Estrada et al.
PLOS ONE (2014)
Contributions of Recent and Past Sexual Partnerships on Incident Human Papillomavirus Detection: Acquisition and Reactivation in Older Women
Anne F. Rositch et al.
CANCER RESEARCH (2012)
Comparison of HPV sign Genotyping Test with INNO-LiPA HPV Genotyping Extra assay on histologic and cytologic cervical specimens
Daniela Barbieri et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Beatriz Serrano et al.
INFECTIOUS AGENTS AND CANCER (2012)
Human Papillomavirus (HPV) Genotypes in Women with Cervical Precancer and Cancer at Kaiser Permanente Northern California
Philip E. Castle et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years
Paula Gonzalez et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy
Francesca M. Carozzi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Evaluation of the Performance of the Novel PapilloCheck® HPV Genotyping Test by Comparison With Two Other Genotyping Systems and the HC2 Test
Betti Schopp et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
The Reproducibility of CIN Diagnoses Among Different Pathologists Data From Histology Reviews From a Multicenter Randomized Study
Paolo Dalla Palma et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Share Paper
